 | • レポートコード：MRC2-11QY06688 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はガンシクロビルのグローバル市場について調査・分析したレポートです。種類別（注射、経口）市場規模、用途別（エイズ、チューブ移植、悪性新生物、CMV感染）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ガンシクロビルの競争状況、市場シェア ・世界のガンシクロビル市場：種類別市場規模 2015年-2020年（注射、経口） ・世界のガンシクロビル市場：種類別市場規模予測 2021年-2026年（注射、経口） ・世界のガンシクロビル市場：用途別市場規模 2015年-2020年（エイズ、チューブ移植、悪性新生物、CMV感染） ・世界のガンシクロビル市場：用途別市場規模予測 2021年-2026年（エイズ、チューブ移植、悪性新生物、CMV感染） ・北米のガンシクロビル市場分析：米国、カナダ ・ヨーロッパのガンシクロビル市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのガンシクロビル市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のガンシクロビル市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのガンシクロビル市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Bausch & Lomb、Fresenius Kabi、Luitpold、Huatai Pharmaceutical、Wuhan Hualong Bio-pharmaceutical、Luoxin、HUBEI KEYI、Tungshun Group、Tiantianming ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Ganciclovir Market
The global Ganciclovir market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ganciclovir Scope and Market Size
Ganciclovir market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ganciclovir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ganciclovir market is segmented into
Injection
Oral
Segment by Application, the Ganciclovir market is segmented into
AIDS
Tube transplant
Malignant neoplasms
CMV Infection
Regional and Country-level Analysis
The Ganciclovir market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ganciclovir market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ganciclovir Market Share Analysis
Ganciclovir market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ganciclovir business, the date to enter into the Ganciclovir market, Ganciclovir product introduction, recent developments, etc.
The major vendors covered:
Roche
Bausch & Lomb
Fresenius Kabi
Luitpold
Huatai Pharmaceutical
Wuhan Hualong Bio-pharmaceutical
Luoxin
HUBEI KEYI
Tungshun Group
Tiantianming
1 Study Coverage
1.1 Ganciclovir Product Introduction
1.2 Market Segments
1.3 Key Ganciclovir Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ganciclovir Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Oral
1.5 Market by Application
1.5.1 Global Ganciclovir Market Size Growth Rate by Application
1.5.2 AIDS
1.5.3 Tube transplant
1.5.4 Malignant neoplasms
1.5.5 CMV Infection
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ganciclovir Market Size, Estimates and Forecasts
2.1.1 Global Ganciclovir Revenue 2015-2026
2.1.2 Global Ganciclovir Sales 2015-2026
2.2 Global Ganciclovir, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ganciclovir Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ganciclovir Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Ganciclovir Competitor Landscape by Players
3.1 Ganciclovir Sales by Manufacturers
3.1.1 Ganciclovir Sales by Manufacturers (2015-2020)
3.1.2 Ganciclovir Sales Market Share by Manufacturers (2015-2020)
3.2 Ganciclovir Revenue by Manufacturers
3.2.1 Ganciclovir Revenue by Manufacturers (2015-2020)
3.2.2 Ganciclovir Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ganciclovir Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ganciclovir Revenue in 2019
3.2.5 Global Ganciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ganciclovir Price by Manufacturers
3.4 Ganciclovir Manufacturing Base Distribution, Product Types
3.4.1 Ganciclovir Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ganciclovir Product Type
3.4.3 Date of International Manufacturers Enter into Ganciclovir Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ganciclovir Market Size by Type (2015-2020)
4.1.1 Global Ganciclovir Sales by Type (2015-2020)
4.1.2 Global Ganciclovir Revenue by Type (2015-2020)
4.1.3 Ganciclovir Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ganciclovir Market Size Forecast by Type (2021-2026)
4.2.1 Global Ganciclovir Sales Forecast by Type (2021-2026)
4.2.2 Global Ganciclovir Revenue Forecast by Type (2021-2026)
4.2.3 Ganciclovir Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ganciclovir Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Ganciclovir Market Size by Application (2015-2020)
5.1.1 Global Ganciclovir Sales by Application (2015-2020)
5.1.2 Global Ganciclovir Revenue by Application (2015-2020)
5.1.3 Ganciclovir Price by Application (2015-2020)
5.2 Ganciclovir Market Size Forecast by Application (2021-2026)
5.2.1 Global Ganciclovir Sales Forecast by Application (2021-2026)
5.2.2 Global Ganciclovir Revenue Forecast by Application (2021-2026)
5.2.3 Global Ganciclovir Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ganciclovir by Country
6.1.1 North America Ganciclovir Sales by Country
6.1.2 North America Ganciclovir Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ganciclovir Market Facts & Figures by Type
6.3 North America Ganciclovir Market Facts & Figures by Application
7 Europe
7.1 Europe Ganciclovir by Country
7.1.1 Europe Ganciclovir Sales by Country
7.1.2 Europe Ganciclovir Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ganciclovir Market Facts & Figures by Type
7.3 Europe Ganciclovir Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Ganciclovir by Region
8.1.1 Asia Pacific Ganciclovir Sales by Region
8.1.2 Asia Pacific Ganciclovir Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ganciclovir Market Facts & Figures by Type
8.3 Asia Pacific Ganciclovir Market Facts & Figures by Application
9 Latin America
9.1 Latin America Ganciclovir by Country
9.1.1 Latin America Ganciclovir Sales by Country
9.1.2 Latin America Ganciclovir Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ganciclovir Market Facts & Figures by Type
9.3 Central & South America Ganciclovir Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Ganciclovir by Country
10.1.1 Middle East and Africa Ganciclovir Sales by Country
10.1.2 Middle East and Africa Ganciclovir Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ganciclovir Market Facts & Figures by Type
10.3 Middle East and Africa Ganciclovir Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Ganciclovir Products Offered
11.1.5 Roche Related Developments
11.2 Bausch & Lomb
11.2.1 Bausch & Lomb Corporation Information
11.2.2 Bausch & Lomb Description and Business Overview
11.2.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bausch & Lomb Ganciclovir Products Offered
11.2.5 Bausch & Lomb Related Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Description and Business Overview
11.3.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Fresenius Kabi Ganciclovir Products Offered
11.3.5 Fresenius Kabi Related Developments
11.4 Luitpold
11.4.1 Luitpold Corporation Information
11.4.2 Luitpold Description and Business Overview
11.4.3 Luitpold Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Luitpold Ganciclovir Products Offered
11.4.5 Luitpold Related Developments
11.5 Huatai Pharmaceutical
11.5.1 Huatai Pharmaceutical Corporation Information
11.5.2 Huatai Pharmaceutical Description and Business Overview
11.5.3 Huatai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Huatai Pharmaceutical Ganciclovir Products Offered
11.5.5 Huatai Pharmaceutical Related Developments
11.6 Wuhan Hualong Bio-pharmaceutical
11.6.1 Wuhan Hualong Bio-pharmaceutical Corporation Information
11.6.2 Wuhan Hualong Bio-pharmaceutical Description and Business Overview
11.6.3 Wuhan Hualong Bio-pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Wuhan Hualong Bio-pharmaceutical Ganciclovir Products Offered
11.6.5 Wuhan Hualong Bio-pharmaceutical Related Developments
11.7 Luoxin
11.7.1 Luoxin Corporation Information
11.7.2 Luoxin Description and Business Overview
11.7.3 Luoxin Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Luoxin Ganciclovir Products Offered
11.7.5 Luoxin Related Developments
11.8 HUBEI KEYI
11.8.1 HUBEI KEYI Corporation Information
11.8.2 HUBEI KEYI Description and Business Overview
11.8.3 HUBEI KEYI Sales, Revenue and Gross Margin (2015-2020)
11.8.4 HUBEI KEYI Ganciclovir Products Offered
11.8.5 HUBEI KEYI Related Developments
11.9 Tungshun Group
11.9.1 Tungshun Group Corporation Information
11.9.2 Tungshun Group Description and Business Overview
11.9.3 Tungshun Group Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Tungshun Group Ganciclovir Products Offered
11.9.5 Tungshun Group Related Developments
11.10 Tiantianming
11.10.1 Tiantianming Corporation Information
11.10.2 Tiantianming Description and Business Overview
11.10.3 Tiantianming Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tiantianming Ganciclovir Products Offered
11.10.5 Tiantianming Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Ganciclovir Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ganciclovir Market Estimates and Projections by Region
12.1.1 Global Ganciclovir Sales Forecast by Regions 2021-2026
12.1.2 Global Ganciclovir Revenue Forecast by Regions 2021-2026
12.2 North America Ganciclovir Market Size Forecast (2021-2026)
12.2.1 North America: Ganciclovir Sales Forecast (2021-2026)
12.2.2 North America: Ganciclovir Revenue Forecast (2021-2026)
12.2.3 North America: Ganciclovir Market Size Forecast by Country (2021-2026)
12.3 Europe Ganciclovir Market Size Forecast (2021-2026)
12.3.1 Europe: Ganciclovir Sales Forecast (2021-2026)
12.3.2 Europe: Ganciclovir Revenue Forecast (2021-2026)
12.3.3 Europe: Ganciclovir Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ganciclovir Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ganciclovir Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ganciclovir Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ganciclovir Market Size Forecast by Region (2021-2026)
12.5 Latin America Ganciclovir Market Size Forecast (2021-2026)
12.5.1 Latin America: Ganciclovir Sales Forecast (2021-2026)
12.5.2 Latin America: Ganciclovir Revenue Forecast (2021-2026)
12.5.3 Latin America: Ganciclovir Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ganciclovir Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ganciclovir Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ganciclovir Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ganciclovir Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ganciclovir Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ganciclovir Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Ganciclovir Market Segments
Table 2. Ranking of Global Top Ganciclovir Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ganciclovir Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Oral
Table 6. Global Ganciclovir Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Ganciclovir Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Ganciclovir Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Ganciclovir Sales Market Share by Regions (2015-2020)
Table 10. Global Ganciclovir Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Ganciclovir Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Ganciclovir Sales Share by Manufacturers (2015-2020)
Table 13. Global Ganciclovir Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Ganciclovir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ganciclovir as of 2019)
Table 15. Ganciclovir Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Ganciclovir Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Ganciclovir Price (2015-2020) (USD/Pcs)
Table 18. Ganciclovir Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Ganciclovir Product Type
Table 20. Date of International Manufacturers Enter into Ganciclovir Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Ganciclovir Sales by Type (2015-2020) (K Pcs)
Table 23. Global Ganciclovir Sales Share by Type (2015-2020)
Table 24. Global Ganciclovir Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Ganciclovir Revenue Share by Type (2015-2020)
Table 26. Ganciclovir Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Ganciclovir Sales by Application (2015-2020) (K Pcs)
Table 28. Global Ganciclovir Sales Share by Application (2015-2020)
Table 29. North America Ganciclovir Sales by Country (2015-2020) (K Pcs)
Table 30. North America Ganciclovir Sales Market Share by Country (2015-2020)
Table 31. North America Ganciclovir Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Ganciclovir Revenue Market Share by Country (2015-2020)
Table 33. North America Ganciclovir Sales by Type (2015-2020) (K Pcs)
Table 34. North America Ganciclovir Sales Market Share by Type (2015-2020)
Table 35. North America Ganciclovir Sales by Application (2015-2020) (K Pcs)
Table 36. North America Ganciclovir Sales Market Share by Application (2015-2020)
Table 37. Europe Ganciclovir Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Ganciclovir Sales Market Share by Country (2015-2020)
Table 39. Europe Ganciclovir Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Ganciclovir Revenue Market Share by Country (2015-2020)
Table 41. Europe Ganciclovir Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Ganciclovir Sales Market Share by Type (2015-2020)
Table 43. Europe Ganciclovir Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Ganciclovir Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Ganciclovir Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Ganciclovir Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Ganciclovir Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Ganciclovir Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Ganciclovir Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Ganciclovir Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Ganciclovir Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Ganciclovir Sales Market Share by Application (2015-2020)
Table 53. Latin America Ganciclovir Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Ganciclovir Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Ganciclovir Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Ganciclovir Revenue Market Share by Country (2015-2020)
Table 57. Latin America Ganciclovir Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Ganciclovir Sales Market Share by Type (2015-2020)
Table 59. Latin America Ganciclovir Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Ganciclovir Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Ganciclovir Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Ganciclovir Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Ganciclovir Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Ganciclovir Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Ganciclovir Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Ganciclovir Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Ganciclovir Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Ganciclovir Sales Market Share by Application (2015-2020)
Table 69. Roche Corporation Information
Table 70. Roche Description and Major Businesses
Table 71. Roche Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. Roche Product
Table 73. Roche Recent Development
Table 74. Bausch & Lomb Corporation Information
Table 75. Bausch & Lomb Description and Major Businesses
Table 76. Bausch & Lomb Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Bausch & Lomb Product
Table 78. Bausch & Lomb Recent Development
Table 79. Fresenius Kabi Corporation Information
Table 80. Fresenius Kabi Description and Major Businesses
Table 81. Fresenius Kabi Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Fresenius Kabi Product
Table 83. Fresenius Kabi Recent Development
Table 84. Luitpold Corporation Information
Table 85. Luitpold Description and Major Businesses
Table 86. Luitpold Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Luitpold Product
Table 88. Luitpold Recent Development
Table 89. Huatai Pharmaceutical Corporation Information
Table 90. Huatai Pharmaceutical Description and Major Businesses
Table 91. Huatai Pharmaceutical Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Huatai Pharmaceutical Product
Table 93. Huatai Pharmaceutical Recent Development
Table 94. Wuhan Hualong Bio-pharmaceutical Corporation Information
Table 95. Wuhan Hualong Bio-pharmaceutical Description and Major Businesses
Table 96. Wuhan Hualong Bio-pharmaceutical Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Wuhan Hualong Bio-pharmaceutical Product
Table 98. Wuhan Hualong Bio-pharmaceutical Recent Development
Table 99. Luoxin Corporation Information
Table 100. Luoxin Description and Major Businesses
Table 101. Luoxin Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Luoxin Product
Table 103. Luoxin Recent Development
Table 104. HUBEI KEYI Corporation Information
Table 105. HUBEI KEYI Description and Major Businesses
Table 106. HUBEI KEYI Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. HUBEI KEYI Product
Table 108. HUBEI KEYI Recent Development
Table 109. Tungshun Group Corporation Information
Table 110. Tungshun Group Description and Major Businesses
Table 111. Tungshun Group Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Tungshun Group Product
Table 113. Tungshun Group Recent Development
Table 114. Tiantianming Corporation Information
Table 115. Tiantianming Description and Major Businesses
Table 116. Tiantianming Ganciclovir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Tiantianming Product
Table 118. Tiantianming Recent Development
Table 119. Global Ganciclovir Sales Forecast by Regions (2021-2026) (K Pcs)
Table 120. Global Ganciclovir Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Ganciclovir Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Ganciclovir Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Ganciclovir Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. North America: Ganciclovir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Ganciclovir Sales Forecast by Country (2021-2026) (K Pcs)
Table 126. Europe: Ganciclovir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Ganciclovir Sales Forecast by Region (2021-2026) (K Pcs)
Table 128. Asia Pacific: Ganciclovir Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Ganciclovir Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Latin America: Ganciclovir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Ganciclovir Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. Middle East and Africa: Ganciclovir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Ganciclovir Players
Table 137. Ganciclovir Customers List
Table 138. Ganciclovir Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Ganciclovir Product Picture
Figure 2. Global Ganciclovir Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Oral Product Picture
Figure 5. Global Ganciclovir Sales Market Share by Application in 2020 & 2026
Figure 6. AIDS
Figure 7. Tube transplant
Figure 8. Malignant neoplasms
Figure 9. CMV Infection
Figure 10. Ganciclovir Report Years Considered
Figure 11. Global Ganciclovir Market Size 2015-2026 (US$ Million)
Figure 12. Global Ganciclovir Sales 2015-2026 (K Pcs)
Figure 13. Global Ganciclovir Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Ganciclovir Sales Market Share by Region (2015-2020)
Figure 15. Global Ganciclovir Sales Market Share by Region in 2019
Figure 16. Global Ganciclovir Revenue Market Share by Region (2015-2020)
Figure 17. Global Ganciclovir Revenue Market Share by Region in 2019
Figure 18. Global Ganciclovir Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Ganciclovir Revenue in 2019
Figure 20. Ganciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Ganciclovir Sales Market Share by Type (2015-2020)
Figure 22. Global Ganciclovir Sales Market Share by Type in 2019
Figure 23. Global Ganciclovir Revenue Market Share by Type (2015-2020)
Figure 24. Global Ganciclovir Revenue Market Share by Type in 2019
Figure 25. Global Ganciclovir Market Share by Price Range (2015-2020)
Figure 26. Global Ganciclovir Sales Market Share by Application (2015-2020)
Figure 27. Global Ganciclovir Sales Market Share by Application in 2019
Figure 28. Global Ganciclovir Revenue Market Share by Application (2015-2020)
Figure 29. Global Ganciclovir Revenue Market Share by Application in 2019
Figure 30. North America Ganciclovir Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Ganciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Ganciclovir Sales Market Share by Country in 2019
Figure 33. North America Ganciclovir Revenue Market Share by Country in 2019
Figure 34. U.S. Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Ganciclovir Market Share by Type in 2019
Figure 39. North America Ganciclovir Market Share by Application in 2019
Figure 40. Europe Ganciclovir Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Ganciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Ganciclovir Sales Market Share by Country in 2019
Figure 43. Europe Ganciclovir Revenue Market Share by Country in 2019
Figure 44. Germany Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Ganciclovir Market Share by Type in 2019
Figure 55. Europe Ganciclovir Market Share by Application in 2019
Figure 56. Asia Pacific Ganciclovir Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Ganciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Ganciclovir Sales Market Share by Region in 2019
Figure 59. Asia Pacific Ganciclovir Revenue Market Share by Region in 2019
Figure 60. China Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Ganciclovir Market Share by Type in 2019
Figure 83. Asia Pacific Ganciclovir Market Share by Application in 2019
Figure 84. Latin America Ganciclovir Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Ganciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Ganciclovir Sales Market Share by Country in 2019
Figure 87. Latin America Ganciclovir Revenue Market Share by Country in 2019
Figure 88. Mexico Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Ganciclovir Market Share by Type in 2019
Figure 95. Latin America Ganciclovir Market Share by Application in 2019
Figure 96. Middle East and Africa Ganciclovir Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Ganciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Ganciclovir Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Ganciclovir Revenue Market Share by Country in 2019
Figure 100. Turkey Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Ganciclovir Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Ganciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Ganciclovir Market Share by Type in 2019
Figure 107. Middle East and Africa Ganciclovir Market Share by Application in 2019
Figure 108. North America Ganciclovir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Ganciclovir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Ganciclovir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Ganciclovir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Ganciclovir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Ganciclovir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Ganciclovir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Ganciclovir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Ganciclovir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Ganciclovir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
サイトメガロウイルス（CMV）感染症の世界市場（～2026年） Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…- サイトメガロウイルス（CMV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cytomegalovirus Therapeutics Scope and Market Size Cytome…
- 悪性リンパ腫の世界市場（～2026年） Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part…
- 悪性中皮腫の世界市場（～2026年） Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the internal organs (known as the mesothelium). Our research indicates that the hospital pharmacies distribution channel segment is expected to witness a significant rise in revenue share over the foreca…
- 悪性神経膠腫の世界市場（～2026年） Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and p…